Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2026-01-24 @ 6:46 AM
Study NCT ID:
NCT00038493
Status:
COMPLETED
Last Update Posted:
2018-10-29
First Post:
2002-05-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide and SCH66336 for Recurrent Glioblastoma Multiforme
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-09-21
Start Date Type:
ACTUAL
Primary Completion Date:
2005-08-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-08-01
Completion Date Type:
ACTUAL
First Submit Date:
2002-05-31
First Submit QC Date:
None
Study First Post Date:
2002-06-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-25
Last Update Post Date:
2018-10-29
Last Update Post Date Type:
ACTUAL